Assessment of Color Vision in Diabetic Patients

NCT03345667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-11-17

No results posted yet for this study

Summary

Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema

Conditions

  • Retinopathy, Diabetic

Interventions

DRUG

lucentis

Use of lucentis and other anti-vegf in patients with diabetic retinopathy

Sponsors & Collaborators

  • Instituto de Olhos de Goiania

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-10-01
Completion
2017-10-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03345667 on ClinicalTrials.gov